• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Prevention of viral hepatitis B with specific gamma globulin. Results of 2 years' experience in a hemodialysis center].

作者信息

Bevilacqua C, Dardi F, Gobbato P, Vidali F, Fayenz L

出版信息

Minerva Med. 1982 Nov 17;73(44):3123-9.

PMID:6183617
Abstract

Prophylaxis with gamma globulins specific for virus hepatitis B was carried out at the Trieste Haemodialysis Centre from December 1979 to December 1981. Since no clear distinction could be drawn between HBsAg-positive dialysed subjects, all staff and patients at the Centre were regarded as constantly at risk for contagion, and hence in the post-exposure state. Those who refused prophylaxis were excluded, together with surface antigen carriers and subjects with antibodies. Specific gamma globulins (Uman-Big) were given at a dose of 0.06 cc/kg at intervals of 90-105 days, together with 0.02 cc/kg standard gamma globulins for conjectured protection against non-A and non-B hepatitis. No allergic reactions worthy of not were observed. Only one patient positivised of all those who underwent continuous prophylaxis. New carriers of HBsAg gradually decreased in number from 1976 to 1981, initially due to the adoption of disposable filters, subsequently owing to partial separation of Au-positives, and finally, in a significant manner, with the introduction of prophylaxis with specific gamma globulins.

摘要

相似文献

1
[Prevention of viral hepatitis B with specific gamma globulin. Results of 2 years' experience in a hemodialysis center].
Minerva Med. 1982 Nov 17;73(44):3123-9.
2
Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.乙肝表面抗原携带者儿童血清乙肝表面抗原清除后对乙肝疫苗的体液免疫和细胞免疫反应
Hepatology. 1996 Dec;24(6):1355-60. doi: 10.1002/hep.510240607.
3
The use of hepatitis B immune globulin (HBIG) in the prevention of hepatitis.
Acta Haematol Pol. 1977 May-Jun;8(2):97-102.
4
Hepatitis B immune serum globulin in prevention of hepatitis B among hospital personnel. Preliminary report from a controlled trial.
Dev Biol Stand. 1975;30:305-9.
5
[Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].[对血液透析患者隐匿性乙型肝炎感染情况的调查]
Mikrobiyol Bul. 2007 Apr;41(2):227-33.
6
[Molecular biology and serologic analysis in an epidemic of viral hepatitis B in vaccinated patients on hemodialysis].
Epidemiol Mikrobiol Imunol. 1999 Nov;48(4):160-6.
7
[Transient blood surface antigens of hepatitis B in patients on hemodialysis].
Rev Clin Esp. 1999 Apr;199(4):198-201.
8
[Prevention and treatment of hepatitis B in patients on hemodialysis and vaccination of hemodialysis health personnel against hepatitis B].血液透析患者的乙型肝炎防治及血液透析医护人员的乙型肝炎疫苗接种
Acta Med Croatica. 2005;59(5):479-82.
9
Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.印度三级护理医院医护人员的认知水平、疫苗接种覆盖率及加强针需求较低。
J Gastroenterol Hepatol. 2008 Nov;23(11):1710-5. doi: 10.1111/j.1440-1746.2008.05483.x. Epub 2008 Aug 28.
10
[New aspects of therapy and prophylaxis of virus hepatitis (author's transl)].
Leber Magen Darm. 1977 Oct;7(5):295-9.